Healthequity Inc (NASDAQ:HQY) – Investment analysts at Barrington Research lowered their FY2019 earnings estimates for Healthequity in a research note issued on Wednesday, December 5th. Barrington Research analyst A. Paris. Jr now anticipates that the company will post earnings of $0.85 per share for the year, down from their previous estimate of $0.87. Barrington Research has a “Outperform” rating and a $100.00 price target on the stock. Barrington Research also issued estimates for Healthequity’s Q4 2019 earnings at $0.14 EPS.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 4th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.02. Healthequity had a net margin of 24.52% and a return on equity of 12.42%. The business had revenue of $70.50 million for the quarter, compared to analysts’ expectations of $69.60 million. During the same period in the previous year, the company earned $0.17 earnings per share. The firm’s revenue for the quarter was up 24.1% compared to the same quarter last year.

Several other brokerages have also commented on HQY. BidaskClub lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Friday. Cantor Fitzgerald lifted their price objective on shares of Healthequity from $80.00 to $82.00 and gave the stock a “neutral” rating in a research report on Thursday. SunTrust Banks lowered shares of Healthequity from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $105.00 to $90.00 in a research report on Thursday. ValuEngine lowered shares of Healthequity from a “strong-buy” rating to a “buy” rating in a research report on Wednesday. Finally, Zacks Investment Research lowered shares of Healthequity from a “buy” rating to a “hold” rating in a research report on Tuesday, November 20th. Six equities research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average price target of $92.08.

Healthequity stock opened at $74.03 on Friday. Healthequity has a fifty-two week low of $42.92 and a fifty-two week high of $101.58. The stock has a market cap of $5.19 billion, a P/E ratio of 137.09, a PEG ratio of 2.90 and a beta of 1.37.

In other news, VP Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction that occurred on Monday, October 22nd. The shares were sold at an average price of $87.01, for a total value of $348,040.00. Following the sale, the vice president now owns 92,500 shares of the company’s stock, valued at $8,048,425. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. In the last three months, insiders sold 12,000 shares of company stock worth $1,027,400. Insiders own 4.00% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of HQY. BlackRock Inc. raised its position in shares of Healthequity by 11.3% in the second quarter. BlackRock Inc. now owns 7,688,768 shares of the company’s stock valued at $577,427,000 after purchasing an additional 777,915 shares during the period. FMR LLC raised its position in shares of Healthequity by 26.5% in the second quarter. FMR LLC now owns 3,410,542 shares of the company’s stock valued at $256,132,000 after purchasing an additional 715,441 shares during the period. Carillon Tower Advisers Inc. raised its position in shares of Healthequity by 751.9% in the second quarter. Carillon Tower Advisers Inc. now owns 752,482 shares of the company’s stock valued at $56,511,000 after purchasing an additional 664,157 shares during the period. Morgan Stanley raised its position in shares of Healthequity by 15.5% in the third quarter. Morgan Stanley now owns 4,001,425 shares of the company’s stock valued at $377,775,000 after purchasing an additional 536,366 shares during the period. Finally, Clearbridge Investments LLC raised its position in shares of Healthequity by 976,643.6% in the third quarter. Clearbridge Investments LLC now owns 380,930 shares of the company’s stock valued at $35,964,000 after purchasing an additional 380,891 shares during the period. 93.01% of the stock is currently owned by institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Story: NASDAQ

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.